S&P 500   4,273.79 (-0.20%)
DOW   33,562.86 (-0.59%)
QQQ   354.90 (+0.07%)
AAPL   179.58 (-0.76%)
MSFT   335.94 (+0.16%)
META   271.39 (-0.45%)
GOOGL   126.01 (+1.07%)
AMZN   125.30 (+0.85%)
TSLA   217.61 (+1.70%)
NVDA   391.71 (-0.40%)
NIO   7.66 (+1.32%)
BABA   84.39 (+0.14%)
AMD   117.93 (+0.06%)
T   15.39 (+1.18%)
F   12.59 (+1.61%)
MU   67.77 (-2.02%)
CGC   0.78 (-4.86%)
GE   104.12 (-1.60%)
DIS   91.00 (+0.25%)
AMC   4.63 (+1.76%)
PFE   38.65 (+0.76%)
PYPL   64.51 (+0.86%)
NFLX   403.54 (+0.77%)
S&P 500   4,273.79 (-0.20%)
DOW   33,562.86 (-0.59%)
QQQ   354.90 (+0.07%)
AAPL   179.58 (-0.76%)
MSFT   335.94 (+0.16%)
META   271.39 (-0.45%)
GOOGL   126.01 (+1.07%)
AMZN   125.30 (+0.85%)
TSLA   217.61 (+1.70%)
NVDA   391.71 (-0.40%)
NIO   7.66 (+1.32%)
BABA   84.39 (+0.14%)
AMD   117.93 (+0.06%)
T   15.39 (+1.18%)
F   12.59 (+1.61%)
MU   67.77 (-2.02%)
CGC   0.78 (-4.86%)
GE   104.12 (-1.60%)
DIS   91.00 (+0.25%)
AMC   4.63 (+1.76%)
PFE   38.65 (+0.76%)
PYPL   64.51 (+0.86%)
NFLX   403.54 (+0.77%)
S&P 500   4,273.79 (-0.20%)
DOW   33,562.86 (-0.59%)
QQQ   354.90 (+0.07%)
AAPL   179.58 (-0.76%)
MSFT   335.94 (+0.16%)
META   271.39 (-0.45%)
GOOGL   126.01 (+1.07%)
AMZN   125.30 (+0.85%)
TSLA   217.61 (+1.70%)
NVDA   391.71 (-0.40%)
NIO   7.66 (+1.32%)
BABA   84.39 (+0.14%)
AMD   117.93 (+0.06%)
T   15.39 (+1.18%)
F   12.59 (+1.61%)
MU   67.77 (-2.02%)
CGC   0.78 (-4.86%)
GE   104.12 (-1.60%)
DIS   91.00 (+0.25%)
AMC   4.63 (+1.76%)
PFE   38.65 (+0.76%)
PYPL   64.51 (+0.86%)
NFLX   403.54 (+0.77%)
S&P 500   4,273.79 (-0.20%)
DOW   33,562.86 (-0.59%)
QQQ   354.90 (+0.07%)
AAPL   179.58 (-0.76%)
MSFT   335.94 (+0.16%)
META   271.39 (-0.45%)
GOOGL   126.01 (+1.07%)
AMZN   125.30 (+0.85%)
TSLA   217.61 (+1.70%)
NVDA   391.71 (-0.40%)
NIO   7.66 (+1.32%)
BABA   84.39 (+0.14%)
AMD   117.93 (+0.06%)
T   15.39 (+1.18%)
F   12.59 (+1.61%)
MU   67.77 (-2.02%)
CGC   0.78 (-4.86%)
GE   104.12 (-1.60%)
DIS   91.00 (+0.25%)
AMC   4.63 (+1.76%)
PFE   38.65 (+0.76%)
PYPL   64.51 (+0.86%)
NFLX   403.54 (+0.77%)
NYSE:BMY

Bristol-Myers Squibb (BMY) News Today

$65.98
+0.32 (+0.49%)
(As of 06/5/2023 ET)
Compare
Today's Range
$65.69
▼
$66.46
50-Day Range
$63.70
▼
$70.74
52-Week Range
$63.07
▼
$81.43
Volume
6.86 million shs
Average Volume
8.12 million shs
Market Capitalization
$138.61 billion
P/E Ratio
19.24
Dividend Yield
3.46%
Price Target
$79.43
ProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability
Get Bristol-Myers Squibb News Delivered to You Automatically

Sign up to receive the latest news and ratings for BMY and its competitors with MarketBeat's FREE daily newsletter.



BMY Media Mentions By Week

BMY Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BMY
News Sentiment
▼
0.08

0.55
▲
Average
Medical
News Sentiment

BMY News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BMY Articles
This Week
▼
18

14
▲
BMY Articles
Average Week

SourceHeadline
benzinga.com logoMEDiC Life Sciences Announces Collaboration with Bristol Myers Squibb on Tumor Target Discovery
benzinga.com - June 5 at 4:04 PM
seekingalpha.com logoBristol-Myers Squibb Weakness Offers Opportunity
seekingalpha.com - June 5 at 12:24 PM
seekingalpha.com logoBristol Myers Squibb: Take The Red Pill
seekingalpha.com - June 5 at 8:05 AM
marketbeat.com logoZacks Research Comments on Bristol-Myers Squibb's FY2023 Earnings (NYSE:BMY)
marketbeat.com - June 5 at 1:44 AM
finance.yahoo.com logoFour-Year Outcomes from Phase 3 CheckMate -9LA Trial Show Durable, Long-Term Survival with Opdivo (nivolumab) Plus Yervoy (ipilimumab) with Two Cycles of Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer
finance.yahoo.com - June 4 at 8:21 AM
marketbeat.com logoFactorial Partners LLC Has $3.19 Million Stock Position in Bristol-Myers Squibb (NYSE:BMY)
marketbeat.com - June 2 at 1:17 PM
finance.yahoo.com logoBristol-Myers Squibb Company (NYSE:BMY) is largely controlled by institutional shareholders who own 78% of the company
finance.yahoo.com - June 2 at 9:24 AM
MarketBeat logoQ2 2023 EPS Estimates for Bristol-Myers Squibb Decreased by Zacks Research (NYSE:BMY)
americanbankingnews.com - June 2 at 7:40 AM
marketbeat.com logoQ2 2023 Earnings Estimate for Bristol-Myers Squibb Issued By Zacks Research (NYSE:BMY)
marketbeat.com - June 2 at 7:39 AM
finance.yahoo.com logoBristol Myers Squibb to Participate in Upcoming Investor Conferences
finance.yahoo.com - June 1 at 8:21 AM
msn.com logoIs Bristol Myers Squibb a Top Dividend Stock?
msn.com - May 31 at 12:00 PM
finance.yahoo.com logoBristol Myers Squibb to Hold R&D Day on September 14
finance.yahoo.com - May 31 at 7:41 AM
finance.yahoo.com logoBristol-Myers Squibb Breaks a Key Support Area: What's Next?
finance.yahoo.com - May 30 at 3:54 PM
marketbeat.com logo Iovance Biotherapeutics Spikes on Melanoma BLA FDA Application (BMY)
marketbeat.com - May 30 at 11:27 AM
msn.com logoHigh Quality Dividend Growth Near 52-Week Lows: Bristol-Myers Squibb Is A Good Bet
msn.com - May 30 at 10:53 AM
finance.yahoo.com logoBristol Myers Squibb to Present Late-Breaking Data for Breyanzi (lisocabtagene maraleucel) in Relapsed or Refractory Follicular Lymphoma and Mantle Cell Lymphoma at 2023 International Conference on Malignant Lymphoma
finance.yahoo.com - May 30 at 10:53 AM
finance.yahoo.com logoU.S. Food and Drug Administration Accepts for Priority Review Bristol Myers Squibb’s Application for Repotrectinib for the Treatment of Patients with Locally Advanced or Metastatic ROS1-Positive Non-Small Cell Lung Cancer
finance.yahoo.com - May 30 at 8:52 AM
247wallst.com logoUnusual Put Option Trade in Bristol-Myers Squibb Worth $520K
247wallst.com - May 26 at 2:32 PM
finance.yahoo.com logoBristol Myers (BMY) Thrombosis Drug Gets Fast Track Designation
finance.yahoo.com - May 26 at 2:32 PM
marketbeat.com logoAmerican International Group Inc. Reduces Stock Holdings in Bristol-Myers Squibb (NYSE:BMY)
marketbeat.com - May 26 at 1:00 PM
msn.com logoBristol Myers' CAR T Cell Therapy Shows Deep, Durable Efficacy In Blood Cancer Patients
msn.com - May 26 at 9:31 AM
finance.yahoo.com logoBristol Myers Squibb Receives Positive CHMP Opinion Recommending Approval for Opdivo (nivolumab) with Chemotherapy as Neoadjuvant Treatment of Resectable Non-Small Cell Lung Cancer at High Risk of Recurrence in Patients with Tumor Cell PD-L1 Expre...
finance.yahoo.com - May 26 at 8:30 AM
businesswire.com logoBristol Myers Squibb to Present First Results at ASCO and EHA from Phase 3 COMMANDS Study of Reblozyl ® (luspatercept-aamt) in First-Line Treatment of Anemia in Adults with ...
businesswire.com - May 25 at 11:31 PM
msn.com logoUnusual Put Option Trade in Bristol-Myers Squibb (BMY) Worth $520.00K
msn.com - May 25 at 9:08 PM
msn.com logoBristol-Myers Squibb Unusual Options Activity
msn.com - May 25 at 6:30 PM
finance.yahoo.com logoBristol Myers Squibb to Present First Results at ASCO and EHA from Phase 3 COMMANDS Study of Reblozyl® (luspatercept-aamt) in First-Line Treatment of Anemia in Adults with Lower-Risk Myelodysplastic Syndromes (MDS)
finance.yahoo.com - May 25 at 6:30 PM
finance.yahoo.com logoBristol Myers Squibb’s Breyanzi (lisocabtagene maraleucel) is First and Only CAR T to Deliver Deep and Durable Efficacy in Pivotal Multicenter Trial in Relapsed or Refractory Chronic Lymphocytic Leukemia, Based on Data Presented at ASCO 2023
finance.yahoo.com - May 25 at 6:30 PM
finance.yahoo.com logoMirati's (MRTX) Sitravatinib Fails Lung Cancer Study, Stock Down 8%
finance.yahoo.com - May 25 at 4:08 PM
finance.yahoo.com logoMilvexian Granted U.S. FDA Fast Track Designation for All Three Indications Under Evaluation in Phase 3 Librexia Program: Ischemic Stroke, Acute Coronary Syndrome and Atrial Fibrillation
finance.yahoo.com - May 25 at 8:30 AM
MarketBeat logoBristol-Myers Squibb (NYSE:BMY) Receives $79.43 Average Target Price from Analysts
americanbankingnews.com - May 24 at 2:12 AM
finance.yahoo.com logoBristol Myers (BMY) Reports Pulmonary Fibrosis Study Results
finance.yahoo.com - May 23 at 3:30 PM
marketbeat.com logoDoximity is an Overlooked Medical Ecosystem AI Play (BMY)
marketbeat.com - May 23 at 8:46 AM
benzinga.com logoBristol Myers Squibb's Investigational LPA1 Antagonist Reduces the Rate of Lung Function Decline in Patients with Idiopathic Pulmonary Fibrosis
benzinga.com - May 22 at 1:41 PM
finance.yahoo.com logoBristol Myers Squibb’s Investigational LPA1 Antagonist Reduces the Rate of Lung Function Decline in Patients with Idiopathic Pulmonary Fibrosis
finance.yahoo.com - May 22 at 1:41 PM
finance.yahoo.com logoBristol-Myers Squibb (NYSE:BMY) sheds 3.3% this week, as yearly returns fall more in line with earnings growth
finance.yahoo.com - May 20 at 9:10 AM
MarketBeat logoStockNews.com Initiates Coverage on Bristol-Myers Squibb (NYSE:BMY)
americanbankingnews.com - May 20 at 3:30 AM
marketbeat.com logoArgonautica Private Wealth Management Inc. Invests $429,000 in Bristol-Myers Squibb (NYSE:BMY)
marketbeat.com - May 19 at 3:28 PM
finance.yahoo.com logo1 Dirt Cheap Dividend Stock to Buy in May
finance.yahoo.com - May 19 at 2:42 PM
nasdaq.com logoWhich Pharmaceuticals Stock Is A Better Pick: Johnson & Johnson Or Eliquis' Maker?
nasdaq.com - May 19 at 8:00 AM
marketbeat.com logoBristol-Myers Squibb (NYSE:BMY) Given Average Rating of "Moderate Buy" by Brokerages
marketbeat.com - May 19 at 4:19 AM
marketbeat.com logoBristol-Myers Squibb Q1 Earnings Transcript
marketbeat.com - May 18 at 7:15 AM
marketbeat.com logoBristol-Myers Squibb (NYSE:BMY) Coverage Initiated by Analysts at StockNews.com
marketbeat.com - May 18 at 3:09 AM
finance.yahoo.com logoPfizer, Amgen, and 7 More Cheap Healthcare Stocks for Investors to Consider
finance.yahoo.com - May 17 at 1:15 PM
MarketBeat logoZacks Research Weighs in on Bristol-Myers Squibb's Q3 2023 Earnings (NYSE:BMY)
americanbankingnews.com - May 17 at 3:36 AM
finance.yahoo.com logoA Closer Look At Bristol-Myers Squibb Company's (NYSE:BMY) Impressive ROE
finance.yahoo.com - May 15 at 9:11 AM
marketbeat.com logoBristol-Myers Squibb Expected to Post Q3 2023 Earnings of $2.00 Per Share (NYSE:BMY)
marketbeat.com - May 15 at 2:55 AM
seekingalpha.com logoBristol-Myers Squibb Company (BMY) Presents at Bank of America Securities 2023 Health Care Conference (Transcript)
seekingalpha.com - May 13 at 7:02 PM
marketbeat.com logoNorth Growth Management Ltd. Sells 32,000 Shares of Bristol-Myers Squibb (NYSE:BMY)
marketbeat.com - May 12 at 1:10 PM
marketbeat.com logoBristol-Myers Squibb (NYSE:BMY) Shares Acquired by First National Advisers LLC
marketbeat.com - May 11 at 1:22 PM
finance.yahoo.com logoIs Bristol-Myers Squibb Stock a Buy Now?
finance.yahoo.com - May 11 at 12:54 PM
Get Bristol-Myers Squibb News Delivered to You Automatically

Sign up to receive the latest news and ratings for BMY and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NYSE:BMY) was last updated on 6/5/2023 by MarketBeat.com Staff

My Account -